Circulating Concentrations of Essential Fatty Acids, Linoleic and α-Linolenic Acid, in US Adults in 2003-2004 and 2011-2012 and the Relation with Risk Factors for Cardiometabolic Disease: An NHANES Analysis
- PMID: 33024926
- PMCID: PMC7524638
- DOI: 10.1093/cdn/nzaa149
Circulating Concentrations of Essential Fatty Acids, Linoleic and α-Linolenic Acid, in US Adults in 2003-2004 and 2011-2012 and the Relation with Risk Factors for Cardiometabolic Disease: An NHANES Analysis
Erratum in
-
Erratum: Circulating Concentrations of Essential Fatty Acids, Linoleic and α-Linolenic Acid, in US Adults in 2003-2004 and 2011-2012 and the Relation with Risk Factors for Cardiometabolic Disease: An NHANES Analysis.Curr Dev Nutr. 2020 Dec 31;4(12):nzaa167. doi: 10.1093/cdn/nzaa167. eCollection 2020 Dec. Curr Dev Nutr. 2020. PMID: 33409443 Free PMC article.
Abstract
Background: The increased use of high-oleic oils to replace trans fat has led to concern about declining intake of PUFA and the potential for essential fatty acid insufficiency or even deficiency.
Objectives: The aim of this study was to examine circulating concentrations of essential and poorly biosynthesized fatty acids, as biomarkers of dietary intake, in the NHANES data sets prior to (2003-2004 cycle) and following (2011-2012 cycle) legislation to reduce trans fat in the food supply and also to explore the associations between these fatty acids and markers of cardiometabolic health.
Methods: Fasting circulating concentrations of fatty acids from adults (aged ≥20 y) in the 2003-2004 and 2011-2012 NHANES cycles were used for analysis. Dietary data from one day of both the 2003-2004 and 2011-2012 cycles were used to examine differences in dietary fatty acid intake between these cycles. Regression analyses were used to assess relations between circulating concentrations of fatty acids and cardiometabolic health.
Results: Between 2003-2004 and 2011-2012, circulating concentrations of linoleic acid (LA) increased (1.38%, P = 0.002); no difference in dietary intake was observed. α-Linolenic acid (ALA), measured by dietary intake (0.14 g, P < 0.001) and circulating concentrations (0.23%, P < 0.01), increased from 2003-2004 to 2011-2012. Circulating LA was inversely associated with BMI (in kg/m2; regression coefficient per percentage point change in LA ± SE: -0.22 ± 0.04), waist circumference (-0.62 ± 0.09 cm), systolic blood pressure (-0.38 ± 0.09 mm Hg), triglycerides (-9.92 ± 0.63 mg/dL), glucose (-3.34 ± 0.13 mg/dL), insulin (-0.18 ± 0.05 µU/mL), and HOMA-IR (-0.29 ± 0.05).
Conclusions: In a nationally representative sample of US adults, no declines in circulating concentrations of essential fatty acids, LA and ALA, were observed between 2003-2004 and 2011-2012, a time when high-oleic oils were increasingly used in the food supply. Higher amounts of circulating LA were correlated with lower risk of cardiometabolic dysfunction, which underscores the importance of monitoring consumption in the United States.
Keywords: cardiometabolic; cardiovascular; essential fatty acids; linoleic acid; monounsaturated fat; omega-3 fatty acids; polyunsaturated fat; trans fat; α-linolenic acid.
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition.
References
-
- Raatz SK, Conrad Z, Jahns L, Belury MA, Picklo MJ. Modeled replacement of traditional soybean and canola oil with high-oleic varieties increases monounsaturated fatty acid and reduces both saturated fatty acid and polyunsaturated fatty acid intake in the US adult population. Am J Clin Nutr. 2018;108(3):594–602. - PubMed
-
- Tarrago-Trani MT, Phillips KM, Lemar LE, Holden JM. New and existing oils and fats used in products with reduced trans-fatty acid content. J Am Diet Assoc. 2006;106(6):867–80. - PubMed
-
- Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG et al. Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2017;136(3):e1–23. - PubMed
-
- FDA Small entity compliance guide: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. (68 FR 41434). [Internet] 2003; [cited December 11, 2019]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents.... - PubMed
-
- FDA Final determination regarding partially hydrogenated oils (removing trans fat). [Internet]. [Cited December 11, 2019]. Available from: https://www.fda.gov/food/food-additives-petitions/final-determination-re...e.
LinkOut - more resources
Full Text Sources